Lumia Health
Lumia Health is dedicated to empowering individuals with chronic blood flow disorders to better self-manage their symptoms through breakthrough wearable technology. Their mission is to make previously unmeasurable symptoms—such as dizziness, brain fog, and fainting—trackable and understandable, especially for those with conditions like POTS, Dysautonomia, Orthostatic Hypotension, Long COVID, and ME/CFS. By combining advanced ear-worn sensors with a companion app, Lumia Health provides real-time insights into blood flow to the head, helping users identify what helps or hinders their well-being. The company collaborates with world-class researchers and medical institutions to ensure the highest standards in research, development, and patient care.
Industries
N/A
Nr. of Employees
small (1-50)
Products
In-ear flow-monitoring wearable initiation kit
A lightweight ear-worn sensor sold with a charging Light Station and carry case; pairs with an iOS app to monitor head blood flow, heart rate, and event-tagged activity over time.
In-ear flow-monitoring wearable initiation kit
A lightweight ear-worn sensor sold with a charging Light Station and carry case; pairs with an iOS app to monitor head blood flow, heart rate, and event-tagged activity over time.
Expertise Areas
- Digital health and remote patient monitoring
- Wearable sensor hardware and ergonomic design
- Cloud-based analytics for physiological data
- Real-time data acquisition and event-driven sampling
Key Technologies
- In-ear wearable sensing
- Bluetooth 5 (BLE) connectivity
- iOS mobile application
- Cloud-based analytics and secure servers
Key People
News & Updates
Lumia Health partners with over 10 research partners and institutions, including Massachusetts General Hospital, MIT, Duke Health, Walter Reed Medical Center, Joslin Diabetes Center, and Dysautonomia International, to advance research and clinical validation of their technology.
Lumia Health partners with over 10 research partners and institutions, including Massachusetts General Hospital, MIT, Duke Health, Walter Reed Medical Center, Joslin Diabetes Center, and Dysautonomia International, to advance research and clinical validation of their technology.